14.2 Contrast Media: Types, Effects & Routes

14.2 Contrast Media: Types, Effects & Routes

Quick Answer: Match the agent and route to the clinical question and risk profile. For IV CT work, expect nonionic low- or iso-osmolar iodinated contrast; screen renal function and apply facility metformin/hydration policies. Use barium for intact GI studies and water-soluble iodinated agents when leak/perforation is a concern. Gadolinium is primarily an MRI agent—know it for multi-modality safety. Power injectors require compatible IV access and continuous extravasation vigilance.

Competencies RTR.5.5–5.7 expect you to select, prepare, and understand effects of contrast media across common radiographic and CT pathways. This section deepens the GI/GU agent choices introduced in Chapter 12 and links them to intravascular CT practice.

Why Contrast Exists

Soft tissues often share similar attenuation. Contrast media raise (or, in some GI double-contrast techniques, help outline) differential attenuation so vessels, lumina, and leaks become visible. Every benefit carries risk: allergic-like reactions, physiologic effects, renal considerations, aspiration, peritoneal injury from barium, and extravasation injury.

Iodinated Contrast: Ionic vs Nonionic, High vs Low Osmolar

Iodine’s high atomic number increases x-ray attenuation. Molecular design drives safety and osmolality:

Physiologic effects patients often feel (IV iodinated)

• Transient warmth or flushing
• Metallic taste
• Mild nausea
• Sense of urinary urgency

These are usually expected pharmacologic/physiologic effects, not automatically “allergic.” Still, monitor for progression to urticaria, bronchospasm, or hypotension (Section 14.3).

Indications (high level)

• CT angiography / multiphase CT: vascular and solid-organ enhancement
• Excretory urography / CT urogram pathways: urinary tract opacification (modality mix is centre-dependent)
• Fluoroscopic urinary studies: when iodinated agents are specified
• GI water-soluble studies: leak, perforation concern, or selected CT oral contrast protocols

Contraindications and cautions (IV iodinated)

Absolute language varies by product monograph and radiologist judgment; RTR screening flags include:

• Prior severe contrast reaction (need risk-benefit, premedication protocols, alternative modality)
• Uncontrolled hyperthyroidism concerns for iodinated agents (specialty consideration)
• Pregnancy: benefit vs risk discussion; modality alternatives when possible
• Renal impairment: risk of post-contrast acute kidney injury (PC-AKI) concepts—screen and hydrate per protocol
• Inability to obtain adequate IV access safely for the required rate
• Known severe allergy to the specific agent class (with specialist planning)

Prior mild reaction is not automatically a hard stop everywhere—but it is a mandatory escalation flag for the protocol in force.

Renal Function, eGFR, Hydration, and Metformin

eGFR / renal function screening

Many Canadian departments use eGFR (estimated glomerular filtration rate) thresholds and risk-factor questionnaires to decide whether IV iodinated contrast proceeds, delays for labs, volume reduction, or alternative imaging is needed. Exact cut-offs are facility- and guideline-era dependent—exam answers should emphasize follow departmental protocol and do not inject when required labs/flags are missing if policy demands them.

Risk factors that commonly trigger lab checks or caution:

• Known CKD, solitary kidney, renal transplant
• Diabetes with renal involvement
• Dehydration, sepsis, acute illness
• Concurrent nephrotoxic drugs (clinical team awareness)
• Advanced age as a contextual risk (not a sole automatic ban)

Hydration

Adequate volume status is a core protective principle before/after IV iodinated contrast in at-risk patients. Oral or IV hydration strategies are protocol-defined (outpatient vs inpatient differ). The RTR reinforces NPO rules without leaving the patient pathologically dry when protocols allow clear fluids, and collaborates on IV hydration orders when present.

Metformin hold policies — Canadian practice principle

Metformin itself is not typically described as “causing” contrast reactions; the concern is lactic acidosis risk if severe acute kidney injury develops after iodinated contrast in susceptible patients. Canadian departmental practice is protocol-dependent:

• Some pathways continue metformin when eGFR is acceptable and the procedure is uncomplicated.
• Others hold metformin for a defined period around contrast in higher-risk renal categories and restart after renal function is rechecked.
• You do not invent a personal hold rule. You screen, flag, and apply the written protocol, escalating to the radiologist/referrer when history and labs conflict with the order.

Document what the patient reports about metformin and what instructions were given per protocol.

Barium Sulfate

• Insoluble suspension → excellent mucosal coating for fluoroscopic GI work when the gut is intact.
• Contraindicated when perforation, free leak, or impending surgery with peritoneal spill risk is suspected → use water-soluble iodinated agents instead.
• Aspiration of large volumes is harmful; never force oral barium in patients with unsafe swallow without pathway modification (e.g., speech-language pathology modified studies).
• Post-care: hydration and awareness of constipation/impaction risk after large barium loads—teach per protocol.

Gadolinium Awareness (MRI — multi-modality knowledge)

RTR primary practice is x-ray/CT/fluoroscopy, but CAMRT clinical principles expect multi-modality literacy:

• Gadolinium-based contrast agents (GBCAs) are used in MRI, not as routine x-ray attenuators.
• Historic concern: nephrogenic systemic fibrosis (NSF) in severe renal failure with certain older agents—MRI services screen renal function and choose macrocyclic/lower-risk agents per modern practice.
• Newer discussions also include gadolinium retention—managed at the MRI protocol level.
• For the RTR exam: know gadolinium ≠ iodinated CT contrast, different risk profile, different modality workflows; do not interchange products or assume identical premedication rules.

Routes: Oral, Rectal, IV, Intrathecal Awareness

If labels, packaging colour conventions, or verbal orders feel ambiguous for intrathecal pathways—hard stop until product identity is confirmed by the responsible physician/pharmacy process.

Power Injector Safety

Power injectors deliver precise multiphase timing (arterial, portal venous, delayed phases).

Safe practice:

1. Use injector-rated peripheral IVs or approved central access types only; know which PICCs/ports are approved in your centre.
2. Confirm patency with saline at a representative rate when protocol requires.
3. Keep tubing air-free; use air detection; hang bags correctly.
4. Enter accurate concentration, volume, rate, and patient weight-based parameters per protocol.
5. Stay at the injector/console with a clear stop path during injection when staffing allows; watch the patient and pressure curve.
6. Warm contrast when department practice supports lower viscosity and patient comfort.
7. After extravasation risk events, quarantine the site and do not “retry at higher rate” blindly.

Pressure alarms exist to protect the patient and equipment—investigate resistance; do not repeatedly override without assessing the IV.

Integrating Indications With Team Communication

Before injection, the RTR often is the last professional to reconcile:

• Clinical indication vs protocol (e.g., stone CT may be non-contrast; multiphase liver needs correct timing)
• Allergy and renal flags vs radiologist decision
• Pregnancy status vs necessity
• Ability to cooperate with breath-holds after contrast timing starts

If anything material is missing or contradictory, delay injection and close the loop. Completing a high-rate injection into an uncertain clinical or access situation is not “efficiency”—it is preventable harm.

Common Exam Traps

1. Selecting barium for suspected GI perforation.
2. Treating all “iodine allergy” stories the same without distinguishing shellfish myths from true prior contrast reactions (still escalate true prior reactions; shellfish is not a reliable proxy).
3. Assuming metformin is universally stopped for every eGFR and every exam without reading the facility rule.
4. Power-injecting through a tiny hand vein at arterial-phase rates.
5. Confusing gadolinium MRI rules with iodinated CT rules.
6. Using a non–intrathecal formulation for myelography.

Master agent classes, routes, and screening logic—the blueprint rewards safe selection more than memorizing every trade name.